SafeCare Magazine Selects Joe Kiani as Person of the Year
SafeCare Magazine announced today that Joe Kiani, Founder of the Patient Safety Movement Foundation and CEO of Masimo, was awarded Person of the Year for 2015. This award recognizes and applauds the one individual who contributed significantly towards improving patient safety and healthcare quality across the globe.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20151005005667/en/
SafeCare Magazine Person of the Year (Photo: Business Wire)
The 64 nominees and finalists included Dr. Victor Dzau, President, Institute of Medicine of the National Academy of Sciences, Dr. James Bagian, former astronaut, Director, Center for Healthcare Engineering, University of Michigan, Dr. Atul Gawande, Surgeon and public health researcher, Dr. Peter Pronovost, SVP for Patient Safety and Quality, Johns Hopkins University of Medicine, Dr. Mark Chassin, President of the Joint Commission, Dr. Ala Alwan, World Health Organization, Dr. Patrick Conway, Chief Medical Officer for Medicare, Dr. Cynthia Deyling, Chief Quality Officer, Cleveland Clinic Health Systems, Dr. David Bates, Chief Innovation Officer, Brigham and Women’s Hospital, Dr. Robert M. Wachter, Professor and Interim Chairman, Department of Medicine at University of California San Francisco, and Dr. Hardeep Singh, Chief, Health Policy, Quality and Informatics Program, Houston Veteran Affairs Health Services Research Center for Innovation.
“We congratulate this year’s 2015 SafeCare Person of the Year - Mr. Kiani,” said Dr. Yisrael M. Safeek, Founder of SafeCare Magazine. “We are incredibly impressed with what he has been able to accomplish in the area of patient safety. Most of our nominees were internationally recognized physicians so the very fact that this year’s award is going to someone without a medical background makes him even more remarkable. For over 25 years, his innovations have revolutionized surgery and critical care medicine. His work with his non-profit Patient Safety Movement Foundation has taken the topic of patient safety and put it at the forefront of those that can impact change. If anyone can achieve zero preventable deaths by 2020, it will be Mr. Joe Kiani.”
SafeCare Magazine’s mission is to deliver information on the people, ideas, organizations and novel technologies affecting safe, efficient and quality healthcare to the sector’s most influential leaders. The publication’s 100 SafeCare Hospital ranking is firmly rooted in the evidence-based framework of the Affordable Care Act, evaluating hospitals in HVBP, HRRP, and HACRP metrics. For more information, please visit www.safecaremagazine.com.
Sarju Bharucha, JD, Editor
800-700-9481 or 859-475-4200
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Westinghouse Electric Company Signs Cooperation Agreement for Lead-Cooled Fast Reactor Development22.2.2018 13:00 | Pressemelding
Westinghouse Electric Company has signed a Cooperation Agreement for lead-cooled fast reactor (LFR) technology development with the Italian National Agency for New Technologies, Energy and Sustainable Economic Development (ENEA) and Ansaldo Nucleare. The agreement demonstrates each party’s commitment to collaborating toward the development of a next-generation nuclear plant based on LFR technology, which is both “walk-away” safe and economically competitive across global energy markets. “This agreement is an exciting step towards the development of a lead-cooled fast reactor for the marketplace,” said Ken Canavan, Westinghouse chief technology officer and vice president, Global Technology Office. “The LFR is game-changing technology for clean energy industries, and Westinghouse is pleased to be working with such experienced partners to bring this innovative concept to fruition.” Beyond baseload electricity generation, the high-temperature operation of the LFR will allow for a broad ran
Mavenir Teams with Dell EMC to Deliver Expanded Cloud-Native NFV Solutions22.2.2018 13:00 | Pressemelding
Mavenir, a leader in mobile network transformation, today announced its collaboration with Dell EMC OEM Solutions to deliver a broad range of solutions for service providers and enterprises covering 5G Cloud RAN, Packet Core, IoT, VoLTE, VoWiFi and RCS on Mavenir’s cloud-native Open Stack NFV and container CloudRange™ platform. Communications service providers are under intense pressure to simultaneously drive new revenue streams and aggressively reduce costs as OTTs gain market share in voice and messaging services. This expanded collaboration directly addresses these challenges, bringing together Mavenir’s extensive software stack for mobile network providers and Dell EMC solutions for infrastructure, cloud and IOT to create new offerings and best practices that enable the cost effective and rapid evolution of service provider and enterprise networks. Mavenir and Dell EMC OEM will pursue advanced engineering engagements in Cloud RAN, IOT and Enterprise Private LTE Solutions, includin
Equifax Integrates Entersekt’s Digital Security System22.2.2018 12:35 | Pressemelding
Entersekt, a leader in push-based authentication and mobile app security, today announced a technology partnership with global information solutions company Equifax Inc. (NYSE:EFX). Equifax has licensed Entersekt’s product Transakt to serve as an additional layer of security protecting the Equifax online and mobile services. Transakt empowers consumers to play an active role in safeguarding their digital identities and accounts. Whenever access to a digital identity or account is required, an authentication request is pushed to their phone or tablet in real time. They approve or block access by simply tapping Accept or Reject. It’s a highly intuitive, one-touch user experience engineered for a mobile-first world. Transakt’s ease of use belies its advanced set of security features. Covered by 56 patents in the United States and elsewhere, the digital-certificate–based technology uniquely identifies each registered mobile device; ensures its continued integrity as a factor of authenticat
ImmerVision to Showcase AI-Ready Vision Technology at MWC 201822.2.2018 12:00 | Pressemelding
ImmerVision, a technology company enabling intelligent vision in all the world’s devices, announced today that it is uniquely prepared to provide AI-ready, data-rich image processing to today’s most incisive device makers and manufacturers. Indeed, ImmerVision is already providing such hyper-intelligent image capture capabilities to some of the world’s top brands. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180222005513/en/ ImmerVision Enables AI-ready intelligent devices include Acer Holo360, Quanta Pi SOLO, and Tamaggo 360LiveCam (Graphic: Business Wire) Based in Montreal, Canada, ImmerVision develops wide-angle panomorph lenses and data-augmented imaging algorithms, enabling creative manufacturers to see more and smarter while creating professional and consumer devices. “In our quest to enable intelligent vision in every device, ImmerVision has taken a great leap forward,” says Alessandro Gasparini, Executive Vice Presi
Kite, a Gilead Company, and Sangamo Therapeutics Announce Collaboration to Develop Next-Generation Engineered Cell Therapies for the Treatment of Cancer22.2.2018 12:00 | Pressemelding
Kite, a Gilead Company (Nasdaq:GILD) and Sangamo Therapeutics, Inc. (Nasdaq:SGMO) today announced the companies have entered into a worldwide collaboration using Sangamo’s zinc finger nuclease (ZFN) technology platform for the development of next-generation ex vivo cell therapies in oncology. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180222005488/en/ Kite will use Sangamo’s ZFN technology to modify genes to develop next-generation cell therapies for autologous and allogeneic use in treating different cancers. Allogeneic cell therapies from healthy donor cells or from renewable stem cells would provide a potential treatment option that can be accessed directly within the oncology infusion center, thus reducing the time to infusion for patients. Under the terms of the agreement, Sangamo will receive an upfront payment of $150 million and is eligible to receive up to $3.01 billion in potential payments, aggregated across 10
CorFlow Presents Fundamental New Insights into the Coronary Microcirculation at ACC22.2.2018 09:10 | Pressemelding
CorFlow Therapeutics AG (www.corflow-therapeutics.ch) today announced that the company will present fundamental new insights into the coronary microcirculation during the annual meeting of the American College of Cardiology (ACC) in Orlando, FL, March 10-12, 2018. CorFlow has since its foundation in June 2016 worked to document that the Controlled Flow Infusion (CoFITM) technology is able to measure the coronary microvascular status and provide therapy to the compromised coronary microcirculation at the same time. Microvascular obstruction (MVO) affects more than half of the acute heart attack patients and is an independent predictor for complications including heart failure which constitutes a high cost burden for the world-wide health care system. To address this large unmet medical need in interventional cardiology, CorFlow has developed an in-vivo model which reproducibly creates MVO in an occlusion-reperfusion model with very low complication rates. Using this in-vivo model, the C